Cargando…

Preclinical testing of a novel personalized cancer vaccine for all solid tumors and all patients

Detalles Bibliográficos
Autores principales:	Jackson, Doreen, Greene, Julia M, Hale, Diane, Schneble, Erika, Wagner, Thomas, Yu, Xianzhong, Peoples, George E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649330/ http://dx.doi.org/10.1186/2051-1426-3-S2-P208

Ejemplares similares

Correlation of HER2/neu antibody response to clinical response in a Phase II trial of the ae37+gm-csf her2 peptide vaccine
por: Greene, Julia, et al.
Publicado: (2014)

Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence
por: Greene, Julia, et al.
Publicado: (2014)

Vaccine-specific T-cell proliferation in response to a dual peptide cancer vaccine in breast and ovarian cancer patients
por: Schneble, Erika J, et al.
Publicado: (2013)

Preliminary report of a clinical trial supporting the sequential use of an attenuated E39 peptide (E39') to optimize the immunologic response to the FBP (E39+GM-CSF) vaccine
por: Jackson, Doreen, et al.
Publicado: (2015)

Preliminary results for the phase 1 trial of a folate receptor alpha adjuvant cancer vaccine in ovarian and endometrial cancer patients
por: Berry, John S, et al.
Publicado: (2013)

36. All headaches are not GCA
por: Jain, Nibha, et al.
Publicado: (2019)

Headache and wine. Are all wines the same?
por: Diaz-Insa, S, et al.
Publicado: (2013)

Programme stoprisk: all about standard precautions
por: Monier, S, et al.
Publicado: (2011)

Why are all phase resetting curves bimodal?
por: Oprisan, Sorinel A, et al.
Publicado: (2013)

What is all the noise about interval timing?
por: Orisan, Sorinel A, et al.
Publicado: (2013)

What happens to all that propofol during prolonged sedation?
por: Cowley, N, et al.
Publicado: (2011)

IntReALL HR and the benefits of adaptive design
por: Holmes, Jane, et al.
Publicado: (2015)

Ventilator associated- respiratory infections (VARI), are all the same?
por: Palomar, M, et al.
Publicado: (2015)

Comorbidites in NPH - local introspective - ‘Shunt them all’!
por: Haylock-Vize, Patricia Anne, et al.
Publicado: (2015)

PA01.47. Making ayurveda affordable and acceptable to all
por: Vatsashyam, Ghanshyam
Publicado: (2012)

Should peanut allergy screening be introduced for all Irish children?
por: Kelleher, Maeve, et al.
Publicado: (2015)

P19-36. Preclinical study of CombiHIVvac vaccine
por: Kaplina, O, et al.
Publicado: (2009)

Group sparse coding with a collection of winner-take-all networks
por: Dyer, Eva L, et al.
Publicado: (2012)

Reproducibility of mild to moderate regurgitation of all heart valves by magnetic resonance imaging
por: Gradinger, Robert, et al.
Publicado: (2011)

Quantum chemical calculations on a unified pH scale for all phases
por: Goll, SK, et al.
Publicado: (2011)

Lactate levels in emergency department patients across all causes of physiologic instability
por: Ødorf, Kimie, et al.
Publicado: (2013)

How to approach patients after Stevens-Johnson syndrome with multiple drug involvement: test or not to test? To attest allergy to all involved drugs without testing?
por: Kinaciyan, Tamar
Publicado: (2014)

The diagnostic accuracy of quantitative CMR perfusion imaging may not be the same for all coronary arteries
por: Morton, Geraint, et al.
Publicado: (2012)

No more Mr Nice Guy – implementation of mandatory seasonal influenza immunization for all personnel
por: Parada, JP, et al.
Publicado: (2011)

Acute kidney injury of all severity is associated with extended hospitalization after critical illness
por: Prowle, JR, et al.
Publicado: (2014)

Optimal hemodynamic management according to the Surviving Sepsis Guidelines is not applicable to all ICU patients
por: Perel, A, et al.
Publicado: (2008)

Temporal sequence learning in reentrantly coupled winner-take-all networks of spiking neurons
por: McKinstry, Jeffrey L
Publicado: (2013)

A new AR therapy (MP29-02*): all of ARIA in one puff
por: Mösges, Ralph, et al.
Publicado: (2015)

Why are all multi-centre trial sites not the same? A network analytic approach
por: McAneney, Helen
Publicado: (2015)

Hand hygiene campaign to all the residential care home for elderly (RCHE) in Hong Kong
por: Leung, J, et al.
Publicado: (2015)

Introducing 'global health methodology research' a knowledge sharing platform open to all
por: van Loggerenberg, Francois, et al.
Publicado: (2013)

Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients
por: Jackson, Doreen O., et al.
Publicado: (2016)

Methotrexate shows the same efficacy and safety in the real world in all subtypes of JIA as in the controlled trial
por: Foedvari, I, et al.
Publicado: (2008)

Managing critically ill oncological patients in hospital: a survey across all ICUs in the UK
por: Gore, C, et al.
Publicado: (2012)

Is an extensive allergy diagnosis workup needed in all cases of suspected hypersensitivity to beta-lactams in children?
por: de Castro, Eunice Dias, et al.
Publicado: (2014)

Precursor B cell all induces irreversible T cell dysfunction not solely dependent on TCR signaling
por: Qin, Haiying, et al.
Publicado: (2015)

P69 Intra-ocular pressure measurement in eye casualty: Which is the Fairest of Them All?
por: Smith, Chanelle, et al.
Publicado: (2021)

P17-26. Effective design of T-cell driven vaccines applied to the GAIA HIV vaccine: advances in vaccine design based on current preclinical success
por: De Groot, AS, et al.
Publicado: (2009)

Estimation of cost-effectiveness in randomised controlled trials when not all participants allocated to active intervention receive it
por: Metcalfe, Chris
Publicado: (2011)

Coarse-grained and all-atom MD simulations with Gromacs based on CELLmicrocosmos 2.2 model membranes
por: Sommer, B, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_a2e2d42ignk7m7h6l26018l1jr